Studies have shown that miR-1908 can target at least 27 genes and is involved in multiple cancer-related signaling pathways, including regulation of the MAPK signaling pathway (6), TGF-β signaling pathway (1, 7), PI3K/AKT signaling pathway (8, 9), and AMPK signaling pathway (10). This evidence concerns the gene TGFB1 and cancer.